Form 13-F position report

ENZON PHARMACEUTICALS INC

Reported by The Goldman Sachs Group Inc

ENZN CUSIP 293904108 Manager CIK 0000886982

Reported 0 shares, down 28,947 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2016
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 13 Through Q2 2016

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for ENZON PHARMACEUTICALS INC held by The Goldman Sachs Group Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

36 managers reported ENZON PHARMACEUTICALS INC for Q2 2016.

Managers reporting ENZON PHARMACEUTICALS INC in Q2 2016.
Manager Activity Shares Change % of reported 13F Reported value Tenure
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM Unchanged 254,200 0 < 0.01% $103,000 13 qtrs
ACADIAN ASSET MANAGEMENT LLC Added 122,287 +8,847 < 0.01% $50,000 12 qtrs
Ancora Advisors LLC New 50,000 +50,000 < 0.01% $20,000 1 qtr
TUDOR INVESTMENT CORP ET AL Unchanged 47,998 0 < 0.01% $19,000 11 qtrs
O SHAUGHNESSY ASSET MANAGEMENT LLC Reduced 11,181 -10,850 < 0.01% $5,000 5 qtrs
MONARCH CAPITAL MANAGEMENT INC Unchanged 10,000 0 < 0.01% $4,000 8 qtrs
ICAHN CARL C Reduced 0 -5,904,863 0 $0 13 qtrs
NORTHERN TRUST CORPORATION Reduced 0 -82,058 0 $0 13 qtrs
FEDERATED HERMES INC Reduced 0 -9,098 0 $0 8 qtrs
DEUTSCHE BANK AG Reduced 0 -420 0 $0 12 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2016
Filed
August 15, 2016
Filing type
13F-HR
Position type
CMN

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.